Clinical Trial Update: Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS [Phase 2]

View source ↗

Summary

Phase 2 trial update on extracellular vesicle infusion for COVID-19-associated ARDS, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Extracellular Vesicle Infusion

Snippet

Sponsor: Direct Biologics, LLC | Conditions: COVID-19, ARDS | Phase 2 | Status: COMPLETED | Results posted: 2023-04-11